Wave Life Sciences (WVE) Change in Acquisitions & Divestments (2022)
Wave Life Sciences' (WVE) quarterly Change in Acquisitions & Divestments came in at $25.0 million in Q4 2022, little changed on a QoQ basis from $25.0 million in Q3 2022.
Powered by 
Analysis
Wave Life Sciences (WVE) Change in Acquisitions & Divestments (2022) Analysis & Trends
Wave Life Sciences (WVE) has 1 years of Change in Acquisitions & Divestments data on file, last reported at $25.0 million in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Wave Life Sciences | 994.54 Mn | 626.53 Mn | - |